Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Spratt

Showing results (411-420 of 666) with videos related to

Pageof 67
Sort By:
The Journal of Urology|September 11, 2016
Very Early Salvage Radiotherapy Improves Distant Metastasis-Free SurvivalAhmed Abugharib, William C Jackson, Vasu Tumati, et al.
Biochemical and Biophysical Research Communications|April 7, 2009
Modulations of benzo[a]pyrene-induced DNA adduct, cyclin D1 and PCNA in oral tissue by 1,4-phenylenebis(methylene)selenocyanateKun-Ming Chen, Peter G Sacks, Thomas E Spratt, et al.
Neurosurgery|September 22, 2019
Local Control and Toxicity of Multilevel Spine Stereotactic Body RadiotherapyWhitney H Beeler, Kelly A Speth, Michael T Broderick, et al.
Neoplasia (New York, N.Y.)|July 6, 2019
Circulating Tumor Cell-Based Molecular Classifier for Predicting Resistance to Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate CancerJae-Seung Chung, Yugang Wang, James Henderson, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2024
Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Exploratory analysis of the SPARTAN trialSoumyajit Roy, Fred Saad, Yilun Sun, et al.
European Urology Oncology|May 11, 2024
Assessing the Clinical Utility of Published Prostate Cancer Polygenic Risk Scores in a Large Biobank Data SetRandy A Vince, Helen Sun, Udit Singhal, et al.
JCO Precision Oncology|August 25, 2020
Clinical Utility of Gene Expression Classifiers in Men With Newly Diagnosed Prostate CancerJonathan C Hu, Jeffrey J Tosoian, Ji Qi, et al.
Prostate Cancer and Prostatic Diseases|August 17, 2021
Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trialsTommy Jiang, Daniela Markovic, Jay Patel, et al.
The EMBO Journal|August 9, 2015
Disruption of the autoinhibited state primes the E3 ligase parkin for activation and catalysisAtul Kumar, Jacob D Aguirre, Tara E C Condos, et al.
BMC Cancer|May 5, 2022
Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancerVipulkumar Dadhania, Daniel Gonzalez, Mustafa Yousif, et al.
Pageof 67

Showing results (411-420 of 666) with videos related to

Sort By:
Pageof 67
The Journal of Urology|September 11, 2016
Very Early Salvage Radiotherapy Improves Distant Metastasis-Free SurvivalAhmed Abugharib, William C Jackson, Vasu Tumati, et al.
Biochemical and Biophysical Research Communications|April 7, 2009
Modulations of benzo[a]pyrene-induced DNA adduct, cyclin D1 and PCNA in oral tissue by 1,4-phenylenebis(methylene)selenocyanateKun-Ming Chen, Peter G Sacks, Thomas E Spratt, et al.
Neurosurgery|September 22, 2019
Local Control and Toxicity of Multilevel Spine Stereotactic Body RadiotherapyWhitney H Beeler, Kelly A Speth, Michael T Broderick, et al.
Neoplasia (New York, N.Y.)|July 6, 2019
Circulating Tumor Cell-Based Molecular Classifier for Predicting Resistance to Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate CancerJae-Seung Chung, Yugang Wang, James Henderson, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2024
Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Exploratory analysis of the SPARTAN trialSoumyajit Roy, Fred Saad, Yilun Sun, et al.
European Urology Oncology|May 11, 2024
Assessing the Clinical Utility of Published Prostate Cancer Polygenic Risk Scores in a Large Biobank Data SetRandy A Vince, Helen Sun, Udit Singhal, et al.
JCO Precision Oncology|August 25, 2020
Clinical Utility of Gene Expression Classifiers in Men With Newly Diagnosed Prostate CancerJonathan C Hu, Jeffrey J Tosoian, Ji Qi, et al.
Prostate Cancer and Prostatic Diseases|August 17, 2021
Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trialsTommy Jiang, Daniela Markovic, Jay Patel, et al.
The EMBO Journal|August 9, 2015
Disruption of the autoinhibited state primes the E3 ligase parkin for activation and catalysisAtul Kumar, Jacob D Aguirre, Tara E C Condos, et al.
BMC Cancer|May 5, 2022
Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancerVipulkumar Dadhania, Daniel Gonzalez, Mustafa Yousif, et al.
Pageof 67